• University of Glasgow Featured PhD Programmes
  • London School of Economics and Political Science Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
  • University of Bristol Featured PhD Programmes
  • University of Mannheim Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • Carlos III Health Institute Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
Wellcome Trust Featured PhD Programmes
Imperial College London Featured PhD Programmes
EPSRC Featured PhD Programmes
University of Nottingham Featured PhD Programmes
University of Bristol Featured PhD Programmes

The regulation of cell migration and cell proliferation and its importance in tumour growth and metastasis.

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

About This PhD Project

Project Description

Understanding the molecular mechanisms that control gene expression is central to understanding cell proliferation, cell migration and tumourigenesis and work in this area has laid the foundations for targeted cancer therapies. We are interested in the regulatory pathways that control the proliferation and migration of normal cells and the events that disrupt this control in tumourigenesis and metastasis. Our focus is the Proline Rich Homeodomain protein (PRH/Hhex), an oligomeric transcription factor that regulates cell proliferation and cell migration in multiple contexts. Changes in PRH localisation and activity are associated with several diseases including prostate cancer, breast cancer, thyroid cancer, liver cancer and some types of leukaemia. This suggests that in some cells PRH functions as a tumour suppressor protein.

Epithelial cells are held tightly together by cell adhesion proteins expressed on the cell surface. However, during Epithelial-Mesenchymal transition (EMT) these cells begin to express different cell adhesion proteins and they start to become more migratory. Transforming Growth Factor-beta (TGFbeta) is up-regulated in many tumours and this protein can induce EMT and increase cell migration. Our recent work has shown that TGFbeta induces EMT-like changes in normal immortalised prostate epithelial cells including changes in cell surface adhesion proteins and changes in cell migration. Our previous work showed that PRH directly regulates transcription of a TGFbeta co-receptor and that this is important for the regulation of prostate cell migration by PRH (Kershaw et al., 2014). In this project we will examine whether PRH counteracts the effects of TGFbeta on EMT and cell migration. The techniques that will be used include mammalian cell culture, western blotting, and cell migration assays.

References

(1) Siddiqui, Y.H., Kershaw, R.M., Humphreys, E. H., Marcolino de Assis Junior, E., Chaudhri, S., Jayaraman, P.-S., and Gaston, K. (2016) CK2 abrogates the inhibitory effects of PRH/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation. Oncogenesis (in press).

(2) Kershaw, R.M., Siddiqui, Y.H., Roberts, D., Jayaraman, P.S. and Gaston, K. (2014) PRH/Hhex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin. Oncogene, 33:5592-600.

(3) Noy, P., Sawasdichai, A., Jayaraman, P.S. and Gaston, K. (2012) Protein kinase CK2 inactivates PRH/Hhex using multiple mechanisms to derepress VEGF signalling and promote cell survival. Nucleic Acids Research, 40: 9008-20.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.
Email Sent

Share this page:

Cookie Policy    X